Cala Health Launches Tremor Relief System Nationwide
The Cala kIQ Plus System is now available in the United States to provide temporary relief for Parkinson and essential tremor.
Updated on Oct. 30, 2026 in Alzheimer’s
Live Poll
Would you prefer noninvasive wearable devices over traditional medication or surgery for treating chronic conditions?
On October 6, 2026, Cala Health began the nationwide distribution of its Cala kIQ Plus System. This noninvasive device uses transcutaneous afferent patterned stimulation to offer temporary hand tremor relief for adults living with essential tremor and Parkinson disease.
Why it matters
The system offers a noninvasive alternative for patients seeking to manage tremors without the need for medications or brain surgery. By utilizing adaptive calibration, the device provides therapy tailored to the daily fluctuations of a patient’s condition.
Clinical data showed that 76% to 89% of patients achieved a reduction of at least 1 point on the TETREAS performance score across three stimulation modes. The system utilizes three distinct stimulation waveform modes to target tremor activity.
The players
Cala Health
This is a medical technology company that develops noninvasive therapies for people with chronic diseases.
The details
The device includes three stimulation waveform modes that users can change at any time. Before each therapy session, the system performs adaptive calibration to ensure the stimulation accounts for daily tremor changes.
Timeline
April 2026: Clinical findings were presented at the AAN Annual Meeting.
October 6, 2026: Cala Health announced the nationwide availability of the device.
Health Landscape
The presentation of these clinical findings at the AAN Annual Meeting follows a long tradition of sharing neurological breakthroughs at major medical conferences. This launch highlights the shift toward noninvasive wearable technologies as viable alternatives to surgical interventions.
Patients with essential tremor or Parkinson disease can now access this noninvasive therapy to manage symptoms in their daily lives. By providing an alternative to surgery or medication, the system offers new flexibility for those seeking tremor reduction.
The takeaway
The Cala kIQ Plus System demonstrates how wearable technology can offer meaningful, noninvasive management for chronic neurological symptoms. Patients should consult their healthcare providers to determine if this therapy fits into their existing tremor management plan.
Further reading
Learn more about the latest innovations in neurodegenerative care on our Alzheimer’s page.
Source note: This article includes information reported by Neurology Advisor.
Live Poll
Would you prefer noninvasive wearable devices over traditional medication or surgery for treating chronic conditions?
